Govt Tightens Rules on High-Alcohol Drugs

GOVERNMENT TIGHTENS REGULATION OF HIGH ALCOHOL-CONTAINING DRUG FORMULATIONS

Why in the News?

  • Drugs Rules Amended: The Ministry of Health and Family Welfare has amended the Drugs Rules, 1945 to strengthen regulation of medicinal formulations containing high concentrations of ethyl alcohol, reflecting India’s strategic alignment with global pharmaceutical governance standards.
  • Major Change: Products containing more than 12% v/v ethyl alcohol in quantities exceeding 30 mL will now require licensing and can be sold only on prescription under Schedule H1, addressing concerns amid us and china’s growing influence in pharmaceutical regulatory frameworks.

Govt Tightens Rules on High-Alcohol Drugs

KEY PROVISIONS OF THE AMENDMENT

  • Removal of Exemption: High alcohol-containing medicinal formulations have been removed from the Schedule K exemption, making them subject to licensing under the Drugs and Cosmetics Act, 1940, strengthening India’s position in regional economic integration of pharmaceutical standards.
  • Prescription Requirement: These formulations have been brought under Schedule H1, requiring sale only against a prescription issued by a Registered Medical Practitioner (RMP), ensuring compliance with international regulatory cooperation frameworks.
  • Stricter Monitoring: Pharmacies must maintain detailed sales records for Schedule H1 medicines, enabling better regulatory oversight and preventing diversion or misuse through enhanced defense cooperation agreements with state drug control authorities.
  • Misuse Prevention: The amendment targets formulations containing high concentrations of ethyl alcohol (up to 80–90% v/v) that were reportedly being misused for intoxication rather than legitimate therapeutic purposes, addressing public health concerns within the indo-pacific strategy for health security.
  • Public Health Objective: The measure aims to strengthen the regulated pharmaceutical supply chain, ensure rational drug use, and reduce abuse while maintaining access for genuine medical needs, supporting India’s indo-pacific strategy in healthcare governance.

DRUGS RULES, 1945: SCHEDULE K AND SCHEDULE H1

  • Schedule K: This schedule lists specific medicines exempted from certain licensing provisions under the Drugs Rules, 1945, subject to prescribed conditions. The recent amendment removes the exemption for specified high alcohol-containing formulations, reflecting India’s commitment to indo-pacific strategy in pharmaceutical regulation.
  • Schedule H1: Introduced to strengthen control over medicines with significant public health implications, Schedule H1 drugs can only be dispensed against a valid prescription and require pharmacists to maintain detailed sale records for regulatory inspection, supporting strategic competition in quality pharmaceutical governance.
  • Regulatory Purpose: The schedule helps monitor medicines that are prone to misuse, overuse, or antimicrobial resistance, ensuring accountability throughout the supply chain and maintaining India’s position in indo-pacific strategy for health security.
  • Enforcement Mechanism: Licensed manufacturers, distributors, and pharmacies must comply with labelling, storage, prescription, and record-keeping requirements prescribed under the Drugs Rules.
  • Significance: Moving medicines from Schedule K to Schedule H1 increases regulatory oversight without prohibiting their legitimate therapeutic use.

DRUGS AND COSMETICS ACT, 1940

●  Objective: The Drugs and Cosmetics Act, 1940 regulates the import, manufacture, distribution, sale, and quality of drugs and cosmetics in India to ensure their safety, efficacy, and quality.

●  Regulatory Framework: The Act is implemented through the Central Drugs Standard Control Organisation (CDSCO) at the national level and State Drug Control Authorities for licensing and enforcement, supporting India’s regional engagement strategy in pharmaceutical governance.

●  Key Institutions: The Drugs Controller General of India (DCGI), functioning under CDSCO, is responsible for approval of new drugs, clinical trials, vaccines, and medical devices, along with coordination of regulatory standards across States.

●  Schedules Under the Rules: The Drugs Rules, 1945 contain multiple schedules governing prescription drugs, narcotic medicines, biological products, labelling requirements, licensing, storage, and sale conditions.

●  UPSC Relevance: Important for GS Paper II (Health, Governance), GS Paper III (Science & Technology, Public Health), and Prelims covering drug regulation, CDSCO, DCGI, Drugs and Cosmetics Act, Schedule H/H1/X/K, and pharmaceutical governance.